在中国的过敏原免疫疗法.
Yaqi Yang1, Wenjing Li1, Rongfei Zhu1,2
1Department of Allergy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Frontiers in allergy
|January 23, 2024
概括
过敏原免疫疗法 (AIT) 有效地减少过敏症状并改善生活质量. 这份审查详细介绍了AITIT的细节.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 免疫疗法研究 免疫疗法研究
- 临床实践审查 临床实践审查
背景情况:
- 过敏原免疫疗法 (AIT) 是一种对过敏性疾病的疾病修饰治疗方法.
- AIT涉及给药过敏原以诱导免疫耐受性.
- 它为终身症状治疗提供了潜在的替代方案.
研究的目的:
- 提供对中国的过敏原免疫疗法 (AIT) 的全面审查.
- 检查AIT的疗效,安全性和当前的临床实践.
- 讨论AIT在中国的未来前景,挑战和机遇.
主要方法:
- 在中国AIT研究和临床研究的文献综述.
- 对AIT疗效和安全性资料的已公布数据的分析.
- 综合有关AIT当前指导方针和可访问性的信息.
主要成果:
- AIT在减少过敏症状和改善患者生活质量方面表现出显著的有效性.
- 目前在中国的AIT实践显示出一个与已建立的安全配置文件的日益增长的趋势.
- 在AIT研究方面取得的进展是显而易见的,目前正在努力扩大其应用.
结论:
- 过敏原免疫疗法是中国对过敏的有价值的病因治疗方法.
- 持续的研究和优化的临床应用对于AIT的进步至关重要.
- 中国在实施广泛的AIT计划方面面临着独特的机遇和挑战.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Antibody Structure
60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
Allergic Drug Reactions
843
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
843
Cross-reactivity
31.1K
Overview
31.1K


